These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21070600)

  • 1. Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.
    Feng DD; Zhang H; Zhang P; Zheng YS; Zhang XJ; Han BW; Luo XQ; Xu L; Zhou H; Qu LH; Chen YQ
    J Cell Mol Med; 2011 Oct; 15(10):2164-75. PubMed ID: 21070600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.
    Zhang H; Li M; Han Y; Hong L; Gong T; Sun L; Zheng X
    Dig Dis Sci; 2010 Sep; 55(9):2545-51. PubMed ID: 19960259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.
    Zhu H; Wu H; Liu X; Evans BR; Medina DJ; Liu CG; Yang JM
    Biochem Pharmacol; 2008 Sep; 76(5):582-8. PubMed ID: 18619946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.
    Shang Y; Zhang Z; Liu Z; Feng B; Ren G; Li K; Zhou L; Sun Y; Li M; Zhou J; An Y; Wu K; Nie Y; Fan D
    Oncogene; 2014 Jun; 33(25):3267-76. PubMed ID: 23893241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.
    Bao L; Hazari S; Mehra S; Kaushal D; Moroz K; Dash S
    Am J Pathol; 2012 Jun; 180(6):2490-503. PubMed ID: 22521303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
    Shi X; Valizadeh A; Mir SM; Asemi Z; Karimian A; Majidina M; Safa A; Yosefi B
    Eur J Pharmacol; 2020 Aug; 880():173138. PubMed ID: 32416187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance.
    Xu Y; Ohms SJ; Li Z; Wang Q; Gong G; Hu Y; Mao Z; Shannon MF; Fan JY
    PLoS One; 2013; 8(11):e82062. PubMed ID: 24303078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-138 might reverse multidrug resistance of leukemia cells.
    Zhao X; Yang L; Hu J; Ruan J
    Leuk Res; 2010 Aug; 34(8):1078-82. PubMed ID: 19896708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.
    Kovalchuk O; Filkowski J; Meservy J; Ilnytskyy Y; Tryndyak VP; Chekhun VF; Pogribny IP
    Mol Cancer Ther; 2008 Jul; 7(7):2152-9. PubMed ID: 18645025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
    Liu Y; Liu X; Yang S
    Biol Pharm Bull; 2021 Jun; 44(6):861-868. PubMed ID: 33828027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux.
    Jain N; Das B; Mallick B
    DNA Repair (Amst); 2022 Jan; 109():103259. PubMed ID: 34871862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin-resistance leukemia cancer cells to treatment.
    Mashayekhi S; Yousefi B; Tohidi E; Darband SG; Mirza-Aghazadeh-Attari M; Sadighparvar S; Kaviani M; Shafiei-Irannejad V; Kafil HS; Karimian A; Jadidi-Niaragh F; Majidinia M
    J Cell Biochem; 2019 Sep; 120(9):15719-15729. PubMed ID: 31087712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein.
    Wang H; Deng Z; Chen X; Cai J; Ma T; Zhong Q; Li R; Li L; Li T
    Med Sci Monit; 2019 Mar; 25():2169-2178. PubMed ID: 30904920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NORAD/miR-202-5p regulates the drug resistance of A549/DDP to cisplatin by targeting P-gp.
    Shen JG; Xu SN; Yin LG
    Gen Physiol Biophys; 2020 Sep; 39(5):481-489. PubMed ID: 33084601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
    Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of P-glycoprotein by miR-27a-3p at the Brain Endothelial Barrier.
    Hammad S; Mabondzo A; Hamoudi R; Harati R
    J Pharm Sci; 2022 May; 111(5):1470-1479. PubMed ID: 34695419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of WT1/+17AA gene expression using RNAi and modulating leukemia cell chemotherapy resistance.
    Shen H; Xu W; Wu Z; Tang H; Xie Y; Zhong X
    Haematologica; 2007 Sep; 92(9):1270-2. PubMed ID: 17768125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.